The complaint filed against the NASDAQ-listed company claims that Insulet failed to maintain adequate manufacturing controls, leading to undisclosed safety risks. Plaintiffs argue that throughout the designated class period, the company issued false and misleading statements to the market, obscuring the true state of its operational infrastructure and the potential impact on customer safety.
Legal representatives from the DJS Law Group are currently organizing the case, inviting shareholders who sustained losses to discuss their rights and potential lead plaintiff appointments. While appointment as a lead plaintiff is an option for eligible investors, it is not a prerequisite for participating in any eventual financial recovery. The firm, led by David J. Schwartz, specializes in securities litigation and is soliciting further contact from affected stakeholders to bolster the claim before the August deadline.




Comments (0)
No comments yet. Be the first!